Argenta is a global animal health contract research, development, and manufacturing organization (CRO CDMO) dedicated to improving the health of animals. With a unique "molecule to market" approach, they offer comprehensive support and tailored solutions for all stages of product development, from drug development to regulatory services and manufacturing.
With a team of over 650 scientists, veterinarians, engineers, and consultants, Argenta has a proven track record of success, producing 1 billion doses of animal health pharmaceuticals annually. They are involved in the development of novel therapies, including monoclonal antibodies and stem cells, and have been recognized as the Best Services Company in the Animal Health Awards for the past six years.
Generated from the website